The FDA is carrying out an important survey of its SCS members., with its results providing crucial evidence for the union's submission to the Senior Salaries Review Body.
The survey is a significant tool for the FDA in arguing the case for pay reform, which as you will know is long overdue in the SCS.
With the ongoing policy of pay restraint likely to be retained for the foreseeable future, it is vital that the Government sees the impact that this has on the SCS.
FDA SCS members can access the survey on the SCS pay area
If you are an FDA SCS member who haven't received notification of the survey, please contact email@example.com so that we can update our records.